Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats

被引:43
作者
Akagi, K
Sano, M
Ogawa, K
Hirose, M
Goshima, H
Shirai, T
机构
[1] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan
关键词
rat; urinary bladder; isothiocyanates; early changes; toxicity;
D O I
10.1080/01926230390202326
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Phenethyl isothiocyanate (PEITC)(1) and benzyl isothiocyanate ( BITC), naturally occurring constituents of cruciferous vegetables, have been reported to exert inhibitory effects against development of tobacco-specific carcinogen-induced lung tumors and are regarded as promising chemopreventive agents for lung cancer. However, tumor promoting and carcinogenic activities in the rat urinary bladder have been detected in several animal models. The purpose of the present study was to investigate early changes in rat urinary bladder epithelium induced by PEITC and BITC and to explore promotion/carcinogenic mechanisms. In the first experiment, in order to assess acute toxic effects, PEITC or BITC at 0.1% each in the diet were administered to 6-week-old F344 rats for 1, 2, 3, and 7 days and sequential histopathological assessment and urinalysis were performed. In the second and third experiments, structure-activity relationships of PEITC, BITC and 8 other analogues, benzyl isocyanate and benzyl thiocyanate, and phenyl-, alpha-naphthyl-, tert-butyl-, butyl-, methyl-, and ethyl isothiocyanates (ITCs) were explored in a 14-day experiment. In the first experiment, the urinary pH was significantly lowered on day 1 by both PEITC and BITC. Striking features of toxicity, such as marked inflammatory changes characterized by cellular infiltration, apoptosis/single cell necrosis, cytoplasmic vacuolation, erosion, and hemorrhage in the urinary bladder were caused, with peaks apparent on days 2 or 3, respectively. Sequential change in 5-bromo-2'-deoxyuridine (BrdU) labeling indices was in line with the inflammatory response, but the thickness of the urinary bladder epithelium continued to gradually increase up to day 7. In the second and third experiments, simple and papillary or nodular (PN) hyperplasias were observed after 14-days treatment with PEITC, BITC, and phenyl- and butyl ITCs. These results suggest that continuous urinary epithelial cell proliferation due to cytotoxicity may play an important role in the early stage of rat urinary bladder carcinogenesis due to oral administration of ITCs. In addition, hydrophobic activity of ITCs, dependent on the alkyl carbon chain length, might strongly influence the induction of bladder lesions in rats.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 49 条
[1]   The disposition of allyl isothiocyanate in the rat and mouse [J].
Bollard, M ;
Stribbling, S ;
Mitchell, S ;
Caldwell, J .
FOOD AND CHEMICAL TOXICOLOGY, 1997, 35 (10-11) :933-943
[2]  
BRUSEWITZ G, 1977, BIOCHEM J, V162, P99
[3]  
CHUNG FL, 1992, CANCER EPIDEM BIOMAR, V1, P383
[4]   CELL-PROLIFERATION IN CARCINOGENESIS [J].
COHEN, SM ;
ELLWEIN, LB .
SCIENCE, 1990, 249 (4972) :1007-1011
[5]   DISTRIBUTION AND METABOLISM OF THE NATURAL ANTICARCINOGEN PHENETHYL ISOTHIOCYANATE IN A-J MICE [J].
EKLIND, KI ;
MORSE, MA ;
CHUNG, FL .
CARCINOGENESIS, 1990, 11 (11) :2033-2036
[6]   THE ROLE OF URINARY PH AND SODIUM-ION CONCENTRATION IN THE PROMOTION STAGE OF 2-STAGE CARCINOGENESIS OF THE RAT URINARY-BLADDER [J].
FUKUSHIMA, S ;
TAMANO, S ;
SHIBATA, MA ;
KURATA, Y ;
HIROSE, M ;
ITO, N .
CARCINOGENESIS, 1988, 9 (07) :1203-1206
[7]  
Fukushima S, 1999, IARC SCI PUBL, P159
[8]  
Futakuchi M, 1998, EUR J CANCER PREV, V7, P153
[9]   Sequential morphological and biological changes in the glandular stomach induced by oral administration of catechol to male F344 rats [J].
Hirose, M ;
Hakoi, K ;
Takahaski, S ;
Hoshiya, T ;
Akagi, K ;
Lin, C ;
Saito, K ;
Kaneko, H ;
Shirai, T .
TOXICOLOGIC PATHOLOGY, 1999, 27 (04) :448-455
[10]  
Hirose M, 1998, INT J CANCER, V77, P773, DOI 10.1002/(SICI)1097-0215(19980831)77:5<773::AID-IJC17>3.0.CO